Evidence map›Paper›PMID 25699089›Full record

ReviewInfectious agents and cancer2014

Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer.

Kenneth Alibek, Stephanie Irving, Zarina Sautbayeva, Ainur Kakpenova, Aliya Bekmurzayeva, Yeldar Baiken, Nurgul Imangali, Madina Shaimerdenova, Damel Mektepbayeva, Arnat Balabiyev and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Infectious agents and cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Interaction of viral oncogenic proteins with the Wnt signaling pathway.Iranian journal of basic medical sciences · 2018
    Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Kenneth AlibekNazarbayev University Research and Innovation System (NURIS), Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana, 010000 Kazakhstan ; National Medical Holding, 2 Syganak Street, Astana, 010000 Kazakhstan.
Stephanie IrvingNazarbayev University Research and Innovation System (NURIS), Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana, 010000 Kazakhstan.
Zarina SautbayevaNazarbayev University Research and Innovation System (NURIS), Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana, 010000 Kazakhstan.
Ainur KakpenovaNazarbayev University Research and Innovation System (NURIS), Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana, 010000 Kazakhstan.
Aliya BekmurzayevaNazarbayev University Research and Innovation System (NURIS), Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana, 010000 Kazakhstan.
Yeldar BaikenNazarbayev University Research and Innovation System (NURIS), Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana, 010000 Kazakhstan.
Nurgul ImangaliSchool of Science and Technology, Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana, 010000 Kazakhstan.
Madina ShaimerdenovaSchool of Science and Technology, Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana, 010000 Kazakhstan.
Damel MektepbayevaNazarbayev University Research and Innovation System (NURIS), Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana, 010000 Kazakhstan.
Arnat BalabiyevNazarbayev University Research and Innovation System (NURIS), Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana, 010000 Kazakhstan.
Aizada ChinybayevaNazarbayev University Research and Innovation System (NURIS), Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana, 010000 Kazakhstan.
Nazarbayev University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Bcl proteins play a critical role in apoptosis, as mutations in family members interfere with normal programmed cell death. Such events can cause cell transformation, potentially leading to cancer. Recent discoveries indicate that some viral proteins interfere with Bcl proteins either directly or indirectly; however, these data have not been systematically described. Some viruses encode proteins that reprogramme host cellular signalling pathways controlling cell differentiation, proliferation, genomic integrity, cell death, and immune system recognition. This review analyses and summarises the existing data and discusses how viral proteins interfere with normal pro- and anti-apoptotic functions of Bcl-2 and Bcl-xL. Particularly, this article focuses on how viral proteins, such as Herpesviruses, HTLV-1, HPV and HCV, block apoptosis and how accumulation of such interference predisposes cancer development. Finally, we discuss possible ways to prevent and treat cancers using a combination of traditional therapies and antiviral preparations that are effective against these viruses.

Indexed as

ApoptosisBcl-2Bcl-xLCancerHepatitis C virusHerpesvirusesHuman papillomavirusHuman T-lymphotropic virus 1Signaling pathwaysTumor suppressor genes

Identifiers

PMID25699089
PMCPMC4333878
OpenAlexW2132677690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.